BriaCell Therapeutics Corp. Liquidation Value
BCTX
Other
Cash & Equivalents
$29.90M
As of 2026-01-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $29.90M
Total Obligations: -$3.19M
$26.72M
Per share: $3.69
Period: 2026-01-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $29.90M
AR: $0
Total Obligations: -$3.19M
$26.72M
Per share: $3.69
Period: 2026-01-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $29.90M
AR: $0
Inventory: $0
Total Obligations: -$3.19M
$26.72M
Per share: $3.69
Period: 2026-01-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $26.72M | $3.69 |
| Liquid Liquidation Value | $26.72M | $3.69 |
| Operating Liquidation Value | $26.72M | $3.69 |
Key Components (as of 2026-01-31)
| Cash & Equivalents | $29.90M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $3.19M |
| Long-term Debt | N/A |
| Op. Lease Liability | N/A |
| Finance Lease | N/A |
| Shares Outstanding | 7.3M |
Explore all 63 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2026-01-31 | $29.90M | N/A | N/A | N/A | $3.19M | N/A | N/A | N/A |
| 2025-10-31 | $2.71M | N/A | N/A | N/A | $3.32M | N/A | N/A | N/A |
| 2025-07-31 | $10.49M | N/A | N/A | N/A | $3.98M | N/A | N/A | N/A |
▼ Community Notes